Lyme Disease

Latest News

The Handoff: Your Week in Rheumatology News - 3/24/17

The Handoff: Your Week in Rheumatology News - 3/24/17

New guidelines for rheumatoid arthritis treatment with DMARDs and money being steered into lupus research highlight this week's The Handoff.

Arthritis Disability Up 20% Since 2002, Says CDC Report

Arthritis Disability Up 20% Since 2002, Says CDC Report

One in four adults in the U.S. have been diagnosed with arthritis.

The Handoff: Your Week in Rheumatology News - 3/3/17

The Handoff: Your Week in Rheumatology News - 3/3/17

Connecticut considers rheumatoid arthritis and fibromyalgia for medical marijuana treatment, while Lyme disease-carrying deer ticks continue to invade Michigan. All this and more in this week's edition.

New-Onset Autoimmune Arthritides After Lyme Disease

New-Onset Autoimmune Arthritides After Lyme Disease

Multiple new-onset systemic autoimmune joint disorders--including rheumatoid and psoriatic arthritis--may develop after Lyme disease treatment.

FDA Updates Safety Labels, Indications for Fluoroquinolone Use

FDA Updates Safety Labels, Indications for Fluoroquinolone Use

Officials with the FDA have approved safety labeling changes for fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections

Increased Number of Suicide Attempts in Patients With Arthritis

Increased Number of Suicide Attempts in Patients With Arthritis

The findings could have important clinical implications in the treatment of patients with arthritis.

Natural Compounds With Anti-Borreliae Effects Identified

Natural Compounds With Anti-Borreliae Effects Identified

Polyphenols (baicalein, luteolin, and rosmarinic acid) and fatty acids (monolaurin and 10-HAD), and micronutrients (iodine and vitamins D3 and C) in combination with doxycycline were effective anti-borreliae substrates

Results From the Persistent Lyme Empiric Antibiotic Study

Results From the Persistent Lyme Empiric Antibiotic Study

Data from the Persistent Lyme Empiric Antibiotic Study Europe (PLEASE) trial assessed whether longer term use of certain antibiotics resulted in improvements in health-related quality of life after open-label treatment with ceftriaxone.

Factors Predicting Biologic Discontinuation in Inflammatory Rheumatic Disease

Factors Predicting Biologic Discontinuation in Inflammatory Rheumatic Disease

Self-discontinuation of biologic medication was associated with 5 predictive factors. Routine assessment for these specific factors in patients with chronic inflammatory rheumatic disease being treated with biologics may increase adherence to treatment.

Low Cost, Mail Based Intervention Reduces Abx Prescribing in Randomized Trial

Low Cost, Mail Based Intervention Reduces Abx Prescribing in Randomized Trial

Providing a low-cost mail-based intervention incorporating social norm feedback on high antibiotic use can consistently reduce such use over a 6-month period, according to a randomized, national study in England.

Sign Up for Free e-newsletters